Medtronic (MDT) Message Board

We're offering Lifetime and discounted 3-year Subscriptions this month only. Details here

To: Dennis who wrote (676)	12/27/2004 10:53:07 AM
From: Jack Hartmann	Read Replies (1) of 681

<A HREF='http://usas1.advfn.com/oasis/oasisc.php?s=45&w=336&h=280&t=_blank' TARGET='_blank'><IMG SRC='http://usas1.advfn.com/oasis/oasisi.php?s=45&w=336&h=280&t=_blank' WIDTH=336 HEIGHT=280 BORDER=0></A>MDT Medtronic undervalued - Barron's (48.14 ) Barron's highlights Medtronic, which is undervalued and should profit from growing defibrillator mkt. J&J is spending $25 bn for Guidant, mainly to get into the mkt. J&J clearly stands among those who believe that the $5 bn defibrillator mkt is one of health care's big growth opportunities. Even so, investors seem to harbor doubt about Medtronic. Its shares have slipped from $54 to $48 in the last month. In fact, after decades as a growth stock that even a conservative investor could own, Medtronic shares have been convalescing between 40 and 50 bucks for most of the past 4 years. Yet Medtronic has several opportunities to quicken interest in its shares. The co trades at 23x next year's projected earnings, compared with roughly 30x earnings for defibrillator rivals Guidant and St. Jude Medical. If the defibrillator mkt stays s
<A HREF='http://usas1.advfn.com/oasis/oasisc.php?s=56&w=750&h=50&t=_blank' TARGET='_blank'><IMG SRC='http://usas1.advfn.com/oasis/oasisi.php?s=56&w=750&h=50&t=_blank' WIDTH=750 HEIGHT=50 BORDER=0></A>